IRON-DEFICIENCY ANEMIA IN PATIENTS RECEIVING ORAL ANTICOAGULANTS
During the previous two decades, novel oral anticoagulants (NOACs) (dabigatran, rivaroxaban, epicasaban, etc.) have been introduced into clinical practice. In a number of studies they proved better efficacy than warfarin. At the same time, finding the optimal balance between the achievement of a cli...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ukrainian Medical Stomatological Academy
2018-11-01
|
| Series: | Вісник проблем біології і медицини |
| Subjects: | |
| Online Access: | https://vpbm.com.ua/upload/2018-4/21-min.pdf |